Table Of Content

JOURNOAF LTH E NEUROLOGICAL SCIENCES Journal of the Neurological Sciences 140 (1996) 143-144 Author Index (Vol. 140) Abe, Y., Doi, K., Katoh, Y., Yamamoto, H., Kataoka, H. and Kawai, S. Hoffman, E.P., see Duggan, D.J. (140) 30 The limit of low speed peripheral nerve elongation; neurological and Horstink, M.W.I.M., see Praamstra, P. (140) 67 circulatory aspects (140) 61 Huygen, P.L.M., see Verhagen, W.I.M. (140) 85 Aii, H., see Katsumi, Y. (140) 46 Alder, H., see Kalman, B. (140) 75 Angelini, C., see Duggan, D.J. (140) 30 Inagaki, T., see Ono, S. (140) 96 Anichini, M., see Malandrini, A. (140) 129 Arts, W.F.M., see Verhagen, W.I.M. (140) 85 Jeng, J.-S., see Liou, H.-H. (140) 53 Jinnai, K., see Ono, S. (140) 96 Biessels, G.J., Stevens, E.J., Mahmood, S.J., Gispen, W.H. and Tomlin- Jénsdéttir, S., see Sveinbjérnsdéttir, S. (140) 101 son, D.R. Insulin partially reverses deficits in peripheral nerve blood flow and conduction in experimental diabetes (140) 12 Kalman, B., Lublin, F.D. and Alder, H. Bignotti, V., see Prelle, A. (140) 132 Characterization of the mitochondrial DNA in patients with multiple Blaauwgeers, H.G.T., De Jong, J.M.B.V., Verspaget, H.W., Van den sclerosis (140) 75 Berg, F.M. and Troost, D. Kanazawa, I., see Hanajima, R. (140) 109 Enhanced superoxide dismutase-2 immunoreactivity of astrocytes and Kanda, F., see Ono, S. (140) 96 occasional neurons in amyotrophic lateral sclerosis (140) 21 Kataoka, H., see Abe, Y. (140) 61 Bléndal, H., see Sveinbjérnsdéttir, S. (140) 101 Katoh, Y., see Abe, Y. (140) 61 Bradley, W.G., see Romano, J.G. (140) 137 Katsumi, Y., Fukuyama, H., Ogawa, M., Matsui, M., Tokonami, F., Aii, H., Sugie, H., Murakami, N. and Nonaka, I. Cesaretti, S., see Malandrini, A. (140) 129 Cerebral oxygen and glucose metabolism in glycogen storage disease Chang, Y.-C., see Liou, H.-H. (140) 53 with normal acid maltase: case report (140) 46 Chen, R.-C., see Liou, H.-H. (140) 53 Kawabata, T., see Nishimura, M. (140) 91 Ciscato, P., see Prelle, A. (140) 132 Kawai, S., see Abe, Y. (140) 61 Collan, Y., see Ma, S.Y. (140) 40 Kim, J.S. Comi, G.P., see Prelle, A. (140) 132 Bilateral perioral sensory symptom after unilateral stroke: Does it Cools, A.R., see Praamstra, P. (140) 67 have a localizing value? (140) 123 Kjartansson, O., see Sveinbjérnsdéttir, S. (140) 101 Kurisaki, H., see Ono, S. (140) 96 De Jong, J.M.B.V., see Blaauwgeers, H.G.T. (140) 21 Kuroki, S., see Nishimura, M. (140) 91 Doi, K., see Abe, Y. (140) 61 Duggan, D.J., Fanin, M., Pegoraro, E., Angelini, C. and Hoffman, E.P. a-Sarcoglycan (adhalin) deficiency: complete deficiency patients are Liou, H.-H., Jeng, J.-S., Chang, Y.-C., Chen, R.-C. and Yip, P.-K. 5% of childhood-onset dystrophin-normal muscular dystrophy and Is ataxic gait the predominant presenting manifestation of Creutzfeldt. most partial deficiency patients do not have gene mutations (140) 30 -Jakob disease? Experience of 14 Chinese cases from Taiwan (140) 53 Fabrizi, G.M., see Malandrini, A. (140) 129 Lublin, F.D., see Kalman, B. (140) 75 Fagiolari, G., see Prelle, A. (140) 132 Fanin, M., see Duggan, D.J. (140) 30 Fisher, M., see Tatlisumak, T. (140) | Ma, S.Y., Rinne, J.O., Collan, Y., R6ytté, M. and Rinne, U.K. Fukuoka, Y., see Ono, S. (140) 96 A quantitative morphometrical study of neuron degeneration in the Fukuyama, H., see Katsumi, Y. (140) 46 substantia nigra in Parkinson’s disease (140) 40 Mahmood, S.J., see Biessels, G.J. (140) 12 Malandrini, A., Cesaretti, S., Mulinari, M., Palmeri, S., Fabrizi, G.M., Gispen, W.H., see Biessels, G.J. (140) 12 Villanova, M., Parrotta, E., Montagnani, A., Montagnani, M., Ani- Green, B., see Romano, J.G. (140) 137 chini, M. and Guazzi, G.C. Guazzi, G.C., see Malandrini, A. (140) 129 Acanthocytosis, retinitis pigmentosa, pallidal degeneration. Report of Gudmundsson, G., see Sveinbjérnsdéttir, S. (140) 101 two cases without serum lipid abnormalities (140) 129 Gudmundsson, G., see Sveinbjérnsdéttir, S. (140) 101 Matsui, M., see Katsumi, Y. (140) 46 Mitake, S., see Ono, S. (140) 96 Hanajima, R., Ugawa, Y., Terao, Y., Ogata, K. and Kanazawa, I. Moggio, M., see Prelle, A. (140) 132 Ipsilateral cortico-cortical inhibition of the motor cortex in various Montagnani, A., see Malandrini, A. (140) 129 neurological disorders (140) 109 Montagnani, M., see Malandrini, A. (140) 129 144 Author Index (Vol. 143) Mulinari, M., see Malandrini, A. (140) 129 Saida, K., see Nishimura, M. (140) 91 Murakami, N., see Katsumi, Y. (140) 46 Saida, T., see Nishimura, M. (140) 91 Scarlato, G., see Prelle, A. (140) 132 Nagao, K., see Ono, S. (140) 96 Schorr, M., Zhou, L. and Schwechheimer, K. Nishimura, M., Saida, T., Kuroki, S., Kawabata, T., Obayashi, H., Saida, Expression of ciliary neurotrophic factor is maintained in spinal motor K. and Uchiyama, T. neurons of amyotrophic lateral sclerosis (140) 117 Post-infectious encephalitis with anti-galactocerebroside antibody sub- Schwechheimer, K., see Schorr, M. (140) 117 sequent to Mycoplasma pneumoniae infection (140) 91 Sciacco, M., see Prelle, A. (140) 132 Nonaka, I., see Katsumi, Y. (140) 46 Stegeman, D.F., see Praamstra, P. (140) 67 Stevens, E.J., see Biessels, G.J. (140) 12 Obayashi, H., see Nishimura, M. (140) 91 Sugie, H., see Katsumi, Y. (140) 46 Ogata, K., see Hanajima, R. (140) 109 Sveinbjérnsdéttir, S., Bléndal, H., Gudmundsson, G., Kjartansson, 6.., Ogawa, M., see Katsumi, Y. (140) 46 Jénsdéttir, S. and Gudmundsson, G. Ono, S., Takahashi, K., Kanda, F., Fukuoka, Y., Jinnai, K., Kurisaki, H., Progressive dementia and leucoencephalopathy as the initial presenta- Mitake, S., Inagaki, T. and Nagao, K. tion of late onset hereditary cystatin-C amyloidosis. Clinicopathologi- Immunohistochemical study of intracytoplasmic inclusion bodies of cal presentation of two cases (140) 101 the thalamus in myotonic dystrophy (140) 96 Takahashi, K., see Ono, S. (140) 96 Palmeri, S., see Malandrini, A. (140) 129 Tatlisumak, T. and Fisher, M. Park-Matsumoto, Y.C. and Tazawa, T. Hematologic disorders associated with ischemic stroke (140) 1 Piperacillin-induced encephalopathy (140) 141 Tazawa, T., see Park-Matsumoto, Y.C. (140) 141 Parrotta, E., see Malandrini, A. (140) 129 Terao, Y., see Hanajima, R. (140) 109 Pegoraro, E., see Duggan, D.J. (140) 30 Tokonami, F., see Katsumi, Y. (140) 46 Praamstra, P., Cools, A.R., Stegeman, D.F. and Horstink, M.W.I.M. Tomlinson, D.R., see Biessels, G.J. (140) 12 Movement-related potential measures of different modes of move- Troost, D., see Blaauwgeers, H.G.T. (140) 21 ment selection in Parkinson's disease (140) 67 Prelle, A., Rigoletto, C., Moggio, M., Sciacco, M., Comi, G.P., Ciscato, Uchiyama, T., see Nishimura, M. (140) 91 P., Fagiolari, G., Rapuzzi, S., Bignotti, V. and Scarlato, G. Ugawa, Y., see Hanajima, R. (140) 109 Asymptomatic familial hyperCKemia associated with desmin accumu- lation in skeletal muscle (140) 132 Van den Berg, F.M., see Blaauwgeers, H.G.T. (140) 21 Verhagen, W.I.M., Huygen, P.L.M. and Arts, W.F.M. Rapuzzi, S., see Prelle, A. (140) 132 Multi-system signs and symptoms in X-linked ataxia carriers (140) 85 Rigoletto, C., see Prelle, A. (140) 132 Verspaget, H.W., see Blaauwgeers, H.G.T. (140) 21 Rinne, J.0., see Ma, S.Y. (140) 40 Villanova, M., see Malandrini, A. (140) 129 Rinne, U.K., see Ma, S.Y. (140) 40 Romano, J.G., Bradley, W.G. and Green, B. Yamamoto, H., see Abe, Y. (140) 61 High cervical myelopathy presenting with the numb clumsy hand Yip, P.-K., see Liou, H.-H. (140) 53 syndrome (140) 137 Réytt, M., see Ma, S.Y. (140) 40 Zhou, L., see Schorr, M. (140) 117 JOURNOAF LTH E NEUROLOGICAL SCIENCES Journal of the Neurological Sciences 140 (1996) 145-146 Subject Index (Vol. 140) Acanthocytosis, (140) 129 Immunohistochemistry, (140) 21, (140) 96 Acute disseminated encephalomyelitis (ADEM), (140) 91 Immunoreaction, (140) 117 Adhalin, (140) 30 Inhibition, (140) 109 ALS, (140) 117 Insulin, (140) 12 Amyloid, (140) 101 Interneuron, (140) 109 Angiopathy, (140) 101 Intracytoplasmic inclusion body, (140) 96 Anticoagulant, (140) 1 Ischemic stroke, (140) 1 Antiphospholipid, (140) 1 a-sarcoglycan, (140) 30 Laser Doppler flowmetry, (140) 12 Ataxic gait, (140) 53 Limb lengthening, (140) 61 Lipoprotein, (140) 129 Basal ganglia, (140) 109 Bilateral, (140) 123 Brain stem auditory evoked potential, (140) 85 Magnetic stimulation, (140) 109 Manifesting heterozygote, (140) 85 Membrane cytoskeleton, (140) 30 Cardiomyopathy, (140) 46 Mental retardation, (140) 46 Cell size, (140) 40 Motor cortex, (140) 67, (140) 109 Cerebral hemorrhages, (140) 101 Movement preparation, (140) 67 Cerebral lesion, (140) 123 Movement-related potentials, (140) 67 Cerebrovascular disorder, (140) 123 Multiple sclerosis, (140) 75 Chinese from Taiwan, (140) 53 Muscular dystrophy, (140) 30 CNTF, (140) 117 Mycoplasma pneumoniae, (140) 91 Coagulation, (140) 1 Myotonic dystrophy, (140) 96 Creutzfeldt-Jakob disease, (140) 53 Dementia, (140) 101 Nerve blood flow, (140) 12, (140) 61 Desmin, (140) 132 Nerve conduction, (140) 12 Desminopathy, (140) 132 Nerve elongation, (140) 61 Diabetic neuropathy, (140) 12 Neuromorphometry, (140) 40 mtDNA variant, (140) 75 Neuron, (140) 117 Dystrophin, (140) 30 Neuropathology, (140) 40 Encephalopathy, (140) 141 Parkinson’s disease, (140) 40, (140) 67 Enzyme-linked immunosorbent assay, (140) 21 Penicillin, (140) 141 Experimental allergic neuritis (EAN), (140) 91 Perioral, (140) 123 External fixator, (140) 61 Peripheral nerve, (140) 61 Piperacillin, (140) 141 Plasma exchange, (140) 91 Familial amyotrophic lateral sclerosis, (140) 21 Positron emission tomography, (140) 46 Free radical, (140) 21 Post-infectious encephalitis, (140) 91 Prion, (140) 53 Galactocerebroside, (140) 91 Proximal myopathy, (140) 46 Genetic susceptibility, (140) 75 Glia, (140) 21 Glycogen storage disease with normal acid maltase, (140) 46 Rabbit, (140) 61 Readiness potential, (140) 67 Hallervorden-Spatz disease, (140) 129 HARP-syndrome, (140) 129 Saccades, (140) 85 HCCA, (140) 101 Sensation, (140) 123 HCHWA, (140) 101 Sensorineural hearing loss, (140) 85 Heparin, (140) 1 Smooth pursuit eye movement, (140) 85 Hereditary, (140) 101 Speech discrimination, (140) 85 HyperCKemia, (140) 132 Sporadic amyotrophic lateral sclerosis, (140) 21 Hypercoagulable state, (140) 1 Streptozotocin-diabetes, (140) 12 146 Subject Index (Vol. 140) Substantia nigra, (140) 40 Ubiquitin, (140) 96 Superoxide dismutases | and 2, (140) 21 Supplementary motor area, (140) 67 Vestibular system, (140) 85 Thalamic inclusion, (140) 96 Warfarin, (140) 1 Thrombosis, (140) 1 Western blot, (140) 117 ' o “ - x, A t. ? A i 7 ia t : * : - : - . cal; oy - & rs a. . x : a ea : 5 Bi . ‘: , ’ . : i o ¢ {